Phase 2 Pancreas Cancer trials recruiting now

All Pancreas Cancer trials, every phase

Other phases for Pancreas Cancer

Phase 2 Pancreas Cancer trials

• A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
  NCT06051695 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 12 locations
• Axelopran for Advanced Cancer in Patients Receiving Opioids
  NCT07354919 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 6 locations
• Bortezomib Combined with PD-1 MAb and MFOLFIRINOX for Metastatic Pancreatic Cancer
  NCT06572813 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
  NCT06006390 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 12 locations
• Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor
  NCT07433283 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 9 locations
• Clinical Safty and Efficacy Study of Infusion of iNKT Cells and CD8+T Cells in Patients With Advanced Solid Tumor
  NCT03093688 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• Early Phase Study of KESONOTIDE™in Participants With Solid Tumours
  NCT06926075 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue Injury
  NCT04485286 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Gemcitabine Versus Reduced-dose Combination Chemotherapy in Fragile Patients with Non-resectable Pancreatic Cancer
  NCT05841420 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Leflunomide or Combination of MEK Inhibitor and Hydroxychloroquine for Refractory Patients With RAS Mutations
  NCT06229340 · Phase: Phase 2 · Ages: 18 Years to 85 Years · Sex: All (male and female) · 1 location
• Milaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study
  NCT06534762 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 2 locations
• Nab-Paclitaxel + Cisplatin + Gemcitabine + TTF in pt. w/ Metastatic PAC
  NCT04605913 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Pancreatic Parenchymal Injection of N-butyl-2-cyanoacrylate
  NCT07230509 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Reinforced Pancreaticojejunostomy With or Without glubran2
  NCT06756074 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
  NCT06580002 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Sintilimab Combined With Chemotherapy and Radiotherapy in Patients With Inoperable Pancreatic Cancer
  NCT06050317 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Stereotactic Body Radiotherapy Plus FAK and RAF/MEK Inhibition in Advanced Pancreatic Adenocarcinoma
  NCT07126158 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Stimulation With Bethanechol in Combination With Gemcitabine and Nab-paclitaxel in Pancreatic Adenocarcinoma
  NCT05241249 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Study of EGFRBi Armed Fresh PBMC in Metastatic or Unresectable Pancreatic Cancer
  NCT06479239 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Surufatinib Plus Camrelizumab and AS in First Line Treatment of Advanced Metastatic Pancreatic Cancer
  NCT05218889 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors
  NCT03755739 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors
  NCT05187338 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 3 locations

Common questions

What does Phase 2 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.